肝细胞癌:分子分类和精确瘤学的过去和现在的挑战和进展
1MedStar Georgetown University Hospital, Lombardi Cancer Center, 3800 Reservoir Rd NW, Washington, DC 20007, USA.
International journal of molecular sciences
|September 9, 2023
概括
肝细胞癌 (HCC) 是一种常见的肝癌,由于其遗传复杂性,其治疗具有挑战性. 最近的进展提供了新的全身疗法,但将治疗方法与个体瘤相匹配仍然很困难.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 基因组学就是基因组学.
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的肝癌,通常是晚诊断的,需要全身治疗.
- 关键的危险因素包括病毒性肝炎,酒精和脂肪肝疾病.
- HCC表现出显著的遗传多样性,使得针对性治疗的开发复杂化.
研究的目的:
- 审查肝细胞癌系统治疗的挑战和最近的进展.
- 讨论HCC的分子异质性及其对治疗策略的影响.
- 突出目前正在努力开发针对肝癌的向疗法.
主要方法:
- 关于肝细胞癌发病因子,危险因素和治疗方法的文献综述.
- 对基因组异常和HCC分子分类的分析.
- 审查最近在肝癌系统性药物开发方面的突破.
主要成果:
- HCC的特点是广泛的基因组不稳定性和多阶段的致癌过程.
- 尽管发现了许多分子亚型,但缺乏统一的治疗共识.
- 最近的药物开发已经扩大了全身治疗的选择,但个性化治疗仍然是一个目标.
结论:
- 肝细胞癌的异质性对有效的全身疗法构成了重大障碍.
- 对分子驱动因素和向药物的持续研究对于改善患者的治疗结果至关重要.
- 在HCC中实现精准医学需要将分子分析与治疗策略相结合.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
1.7K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K